In response to a variety of chronic stimuli, such as NAFLD, HSCs may acquire a pro-fibrogenic-activated phenotype, in which TGF-β acts as a pivotal driver. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.